Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 14 studies | 29% ± 12% | |
oligodendrocyte | 10 studies | 27% ± 10% | |
oligodendrocyte precursor cell | 9 studies | 26% ± 12% | |
glutamatergic neuron | 8 studies | 38% ± 26% | |
microglial cell | 7 studies | 26% ± 8% | |
astrocyte | 7 studies | 31% ± 13% | |
macrophage | 6 studies | 29% ± 6% | |
epithelial cell | 6 studies | 30% ± 13% | |
GABAergic neuron | 6 studies | 40% ± 21% | |
neuron | 5 studies | 34% ± 15% | |
interneuron | 5 studies | 39% ± 23% | |
endothelial cell of lymphatic vessel | 5 studies | 23% ± 6% | |
fibroblast | 5 studies | 20% ± 5% | |
granule cell | 4 studies | 19% ± 3% | |
ciliated cell | 4 studies | 25% ± 6% | |
monocyte | 3 studies | 21% ± 3% | |
type I pneumocyte | 3 studies | 21% ± 6% | |
lymphocyte | 3 studies | 26% ± 7% | |
goblet cell | 3 studies | 35% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 5079.33 | 21 / 21 | 100% | 22.93 | 504 / 504 |
esophagus | 100% | 4531.07 | 1445 / 1445 | 100% | 32.39 | 183 / 183 |
lung | 100% | 4344.28 | 578 / 578 | 100% | 22.50 | 1153 / 1155 |
stomach | 100% | 3590.69 | 359 / 359 | 100% | 27.26 | 285 / 286 |
breast | 100% | 4552.63 | 459 / 459 | 100% | 39.05 | 1114 / 1118 |
prostate | 100% | 5034.76 | 245 / 245 | 100% | 28.02 | 500 / 502 |
brain | 99% | 3609.04 | 2627 / 2642 | 100% | 20.88 | 705 / 705 |
thymus | 100% | 5298.85 | 653 / 653 | 99% | 24.39 | 601 / 605 |
intestine | 100% | 4739.55 | 966 / 966 | 99% | 23.67 | 523 / 527 |
ovary | 100% | 4189.63 | 180 / 180 | 99% | 22.17 | 426 / 430 |
adrenal gland | 100% | 4627.91 | 258 / 258 | 99% | 19.78 | 227 / 230 |
uterus | 100% | 4900.84 | 170 / 170 | 99% | 20.66 | 453 / 459 |
pancreas | 100% | 2412.54 | 327 / 328 | 99% | 18.91 | 176 / 178 |
kidney | 100% | 3418.22 | 89 / 89 | 98% | 19.20 | 887 / 901 |
skin | 100% | 5365.95 | 1809 / 1809 | 97% | 25.34 | 458 / 472 |
liver | 100% | 1659.49 | 226 / 226 | 73% | 8.05 | 298 / 406 |
adipose | 100% | 4031.53 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4309.32 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.09 | 29 / 29 |
muscle | 100% | 3156.69 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4725.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.68 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.19 | 1 / 1 |
heart | 99% | 2727.26 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 2357.13 | 856 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 11.66 | 69 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | RALGAPB |
Protein name | Ral GTPase-activating protein subunit beta Ral GTPase activating protein non-catalytic subunit beta Ral GTPase-activating protein subunit beta (p170) |
Synonyms | KIAA1219 |
Description | FUNCTION: Non-catalytic subunit of the heterodimeric RalGAP1 and RalGAP2 complexes which act as GTPase activators for the Ras-like small GTPases RALA and RALB. . |
Accessions | Q86X10 ENST00000632792.1 ENST00000438490.2 ENST00000397042.7 [Q86X10-3] ENST00000262879.11 [Q86X10-1] A2A2F0 G1UI28 A0A0J9YW54 ENST00000397040.5 [Q86X10-1] |